Unnamed: 0,title,date,stock,sentiment
1412043.0,"Shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some US states that have reopened, leading to concerns of a second wave of the virus.",2020-06-11 10:22:00-04:00,ZTS,positive
1412044.0,"UBS Maintains Neutral on Zoetis, Lowers Price Target to $126",2020-05-08 14:23:00-04:00,ZTS,negative
1412045.0,"Citigroup Maintains Neutral on Zoetis, Lowers Price Target to $131",2020-05-08 08:33:00-04:00,ZTS,negative
1412046.0,"Barclays Maintains Overweight on Zoetis, Raises Price Target to $140",2020-05-07 11:17:00-04:00,ZTS,negative
1412047.0,Zoetis shares are trading lower after the company issued FY20 EPS and sales guidance below analyst estimates.,2020-05-06 09:03:00-04:00,ZTS,neutral
1412048.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,ZTS,positive
1412049.0,"Zoetis Sees FY20 Adj. EPS $3.17-$3.42 vs $3.71 Est., Sales $5.95B-$6.25B vs $6.43B Est.",2020-05-06 07:05:00-04:00,ZTS,neutral
1412050.0,"Zoetis Q1 Adj. EPS $0.950 Beats $0.860 Estimate, Sales $1.500B Inline",2020-05-06 07:03:00-04:00,ZTS,neutral
1412051.0,"Earnings Scheduled For May 6, 2020",2020-05-06 04:36:00-04:00,ZTS,neutral
1412052.0,Shares of several healthcare companies are trading higher amid positive investor sentiment as some US states begin to reopen their economies and as oil prices gain for the session.,2020-05-05 12:44:00-04:00,ZTS,positive
1412053.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,ZTS,neutral
1412054.0,Three High-Quality Companies To Bet On In A Post-Coronavirus World,2020-04-29 06:10:00-04:00,ZTS,neutral
1412055.0,"Shares of several healthcare companies are trading lower with the overall market on continued downward momentum after oil prices fell to historic lows, partially stemming from weak demand caused by the coronavirus pandemic.",2020-04-21 11:35:00-04:00,ZTS,negative
1412056.0,FDA Says Closely Monitoring Potential For New Animal Drug Shortages And Supply Chain Disruptions,2020-04-16 14:20:00-04:00,ZTS,negative
1412057.0,Shares of several healthcare companies are trading higher as markets gain on positive coronavirus outlook. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-14 10:59:00-04:00,ZTS,positive
1412058.0,"Shares of several healthcare companies are trading lower amid overall market weakness. Stocks are lower, selling off from last week's gains amid uncertainty surrounding coronavirus outlook and the reopening of the economy.",2020-04-13 12:23:00-04:00,ZTS,negative
1412059.0,Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.,2020-04-06 09:42:00-04:00,ZTS,positive
1412060.0,"Morgan Stanley Maintains Equal-Weight on Zoetis, Lowers Price Target to $125",2020-04-02 09:27:00-04:00,ZTS,negative
1412061.0,Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.,2020-04-01 09:20:00-04:00,ZTS,negative
1412062.0,Shares of several healthcare companies are trading higher as the market rebounds on extended measures to help curb the coronavirus. NOTE: The sector could also be trading higher due to increased demand for medical products amid the coronavirus outbreak.,2020-03-30 10:17:00-04:00,ZTS,positive
1412063.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 10:58:00-04:00,ZTS,positive
1412064.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,ZTS,negative
1412065.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,ZTS,negative
1412066.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,ZTS,neutral
1412067.0,"Zoetis Shares Up 5% After Hours; SunTrust Earlier Discussed Expectations Drugmakers Won't See Near-Term Debt Crisis, Sees Co., Jazz Pharma As Strongest Positioned In Terms Of Debt, Leverage",2020-03-18 16:16:00-04:00,ZTS,positive
1412068.0,"Shares of several healthcare companies are trading lower as the coronavirus outbreak continues to cause economic disruption around the globe, leading to a steep selloff in equities across sectors.",2020-03-16 10:50:00-04:00,ZTS,negative
1412069.0,Shares of several healthcare  companies are trading lower. Movement appears market-related as markets continue to dip amid the global coronavirus outbreak and OPEC failing to reach production agreement.,2020-03-09 10:55:00-04:00,ZTS,neutral
1412070.0,Shares of several healthcare companies are trading lower. Movement appears market related as markets continue to dip amid the global coronavirus outbreak.,2020-03-06 09:11:00-05:00,ZTS,neutral
1412071.0,Shares of several healthcare companies are trading higher in sympathy with the overall market as it rebounds from a selloff caused by coronavirus fears.,2020-03-02 11:18:00-05:00,ZTS,positive
1412072.0,"Zoetis Receives FDA Approval For Simparica Trio, A New Combination Parasite Preventative For Dogs",2020-02-27 14:01:00-05:00,ZTS,positive
1412073.0,Shares of several healthcare and biotech companies are trading higher. Not seeing any news to justify the price action.,2020-02-26 14:28:00-05:00,ZTS,positive
1412074.0,Shares of several healthcare and biotech companies are trading higher. Movement appears market related as equities have rebounded this session following recent selloffs.,2020-02-26 11:19:00-05:00,ZTS,positive
1412075.0,"UBS Maintains Neutral on Zoetis, Raises Price Target to $146",2020-02-19 07:49:00-05:00,ZTS,neutral
1412076.0,"Morgan Stanley Maintains Equal-Weight on Zoetis, Raises Price Target to $148",2020-02-14 09:19:00-05:00,ZTS,neutral
1412077.0,"The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering",2020-02-14 08:23:00-05:00,ZTS,negative
1412078.0,Zoetis shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.,2020-02-13 15:00:00-05:00,ZTS,positive
1412079.0,"CFRA Upgrades Zoetis to Strong Buy, Raises Price Target to $160",2020-02-13 12:44:00-05:00,ZTS,positive
1412080.0,"The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO",2020-02-13 08:05:00-05:00,ZTS,negative
1412081.0,"Zoetis Sees FY20 Adj. EPS $3.90-$4 vs $4.01 Estimate, Sales $6.65B-$6.8B vs $6.7B Est.",2020-02-13 07:02:00-05:00,ZTS,neutral
1412082.0,"Zoetis Q4 Adj. EPS $0.92 Beats $0.88 Estimate, Sales $1.674B Beat $1.64B Estimate",2020-02-13 07:01:00-05:00,ZTS,neutral
1412083.0,"Earnings Scheduled For February 13, 2020",2020-02-13 04:27:00-05:00,ZTS,neutral
1412084.0,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data",2020-02-12 09:18:00-05:00,ZTS,positive
1412085.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-11 10:17:00-05:00,ZTS,neutral
1412086.0,The Week Ahead In Biotech: SMID-Cap Earnings In The Spotlight,2020-02-09 15:22:00-05:00,ZTS,neutral
1412087.0,ï»¿Shares of several healthcare companies are trading lower as fears of the coronavirus' potential impact on the global economy intensifies. The death toll continues to rise and the U.K. and Russia confirmed their first cases.,2020-01-31 11:41:00-05:00,ZTS,negative
1412088.0,Zoetis shares are trading lower. Not seeing any news to justify the price action.,2020-01-23 11:58:00-05:00,ZTS,neutral
1412089.0,"The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment",2020-01-23 07:24:00-05:00,ZTS,positive
1412090.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-22 10:17:00-05:00,ZTS,neutral
1412091.0,"The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings",2020-01-22 08:25:00-05:00,ZTS,neutral
1412092.0,Stocks That Hit 52-Week Highs On Tuesday,2020-01-21 10:11:00-05:00,ZTS,neutral
1412093.0,Stocks That Hit 52-Week Highs On Friday,2020-01-17 13:23:00-05:00,ZTS,neutral
1412094.0,"The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares",2020-01-17 08:07:00-05:00,ZTS,negative
1412095.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-16 10:22:00-05:00,ZTS,neutral
1412096.0,"The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics",2020-01-16 07:22:00-05:00,ZTS,neutral
1412097.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-15 13:14:00-05:00,ZTS,neutral
1412098.0,"The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance",2020-01-15 08:22:00-05:00,ZTS,negative
1412099.0,"The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug",2020-01-14 07:55:00-05:00,ZTS,positive
1412100.0,"Benzinga's Top Upgrades, Downgrades For January 10, 2020",2020-01-10 12:16:00-05:00,ZTS,positive
1412101.0,Raymond James Initiates Coverage On Zoetis with Market Perform Rating,2020-01-10 09:23:00-05:00,ZTS,neutral
1412102.0,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx",2020-01-10 07:13:00-05:00,ZTS,positive
1412103.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-09 15:15:00-05:00,ZTS,neutral
1412104.0,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results",2020-01-09 08:39:00-05:00,ZTS,positive
1412105.0,"The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger",2020-01-03 07:55:00-05:00,ZTS,negative
1412106.0,Stocks That Hit 52-Week Highs On Friday,2019-12-20 11:59:00-05:00,ZTS,neutral
1412107.0,Zoetis shares are trading higher. The stock moved higher following unusual interest in the July $140 call contract.,2019-12-20 11:49:00-05:00,ZTS,positive
1412108.0,Zoetis Raises Quarterly Dividend From $0.164 To $0.20/Share,2019-12-11 16:23:00-05:00,ZTS,neutral
1412109.0,Shares of several healthcare stocks are trading lower as US equities dip following escalating US-China tensions over Hong Kong. US Stocks further fell on worse-than-expected manufacturing data.,2019-12-02 11:31:00-05:00,ZTS,negative
1412110.0,"Zoetis Reports Purchase Of ZNLabs, No Terms Disclosed",2019-11-22 08:03:00-05:00,ZTS,negative
1412111.0,Boring No More: Agriculture and Food Investing Gets A Sexy New ETF,2019-11-15 07:17:00-05:00,ZTS,neutral
1412112.0,Zoetis shares are trading lower despite the company reporting better-than-expected Q3 EPS and sales results.,2019-11-08 11:28:00-05:00,ZTS,neutral
1412113.0,"JP Morgan Maintains Overweight on Zoetis, Raises Price Target to $150",2019-11-08 08:28:00-05:00,ZTS,neutral
1412114.0,Morgan Stanley Upgrades Elanco Animal Health On Valuation,2019-11-07 13:30:00-05:00,ZTS,neutral
1412115.0,"Zoetis Sees FY19 Guidance: Adj. EPS $3.57-$3.62 vs $3.57 Estimate, Sales $6.2B-$6.25B vs $6.24B Est.",2019-11-07 08:12:00-05:00,ZTS,neutral
1412116.0,"Zoetis Q3 EPS $0.94 Beats $0.88 Estimate, Sales $1.584B Beat $1.58B Estimate",2019-11-07 08:11:00-05:00,ZTS,neutral
1412117.0,"The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs",2019-11-07 07:18:00-05:00,ZTS,negative
1412118.0,"Earnings Scheduled For November 7, 2019",2019-11-07 04:22:00-05:00,ZTS,neutral
1412119.0,A Preview Of Zoetis' Q3 Earnings,2019-11-06 13:27:00-05:00,ZTS,neutral
1412120.0,Zoetis shares are trading lower in sympathy with Mylan after the company reported worse-than-expected sales and issued inline guidance.,2019-11-05 11:07:00-05:00,ZTS,positive
1412121.0,Zoetis shares are trading lower. Not seeing any news to justify the price action.,2019-10-22 15:32:00-04:00,ZTS,neutral
1412122.0,"The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch",2019-10-16 07:06:00-04:00,ZTS,positive
1412123.0,Stocks That Hit 52-Week Highs On Tuesday,2019-10-15 10:32:00-04:00,ZTS,neutral
1412124.0,Zoetis Reports CEO Juan Ramon Alaix To Retire; Kristin Peck Named Successor,2019-10-03 07:16:00-04:00,ZTS,positive
1412125.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued fears of a recession amid a weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week.,2019-10-02 10:33:00-04:00,ZTS,negative
1412126.0,"Morgan Stanley Maintains Equal-Weight on Zoetis, Raises Price Target to $136",2019-09-30 08:35:00-04:00,ZTS,neutral
1412127.0,Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival.,2019-09-20 13:00:00-04:00,ZTS,negative
1412128.0,"European Commission Grants Marketing Authorization To Simparica Trio, A Once-Monthly Triple Combination Antiparasitic Medication for Dogs",2019-09-20 09:03:00-04:00,ZTS,positive
1412129.0,Shares of several drugmakers are trading lower on news of a drug pricing bill being developed by House Democrats. The proposed bill would set US drug prices based on prices in other wealthy countries.,2019-09-10 10:30:00-04:00,ZTS,positive
1412130.0,"The Daily Biotech Pulse: Translate Bio Halts mRNA Therapy Trial, Roche Multiple Sclerosis Biomarker Data, D-Day For Xeris",2019-09-10 07:36:00-04:00,ZTS,neutral
1412131.0,Zoetis Scientists Present Positive Efficacy Data for Investigational Triple Combination Parasiticide at American Heartworm Society Meeting,2019-09-09 16:31:00-04:00,ZTS,positive
1412132.0,"The Daily Biotech Pulse: FDA Likes Nabriva's Antibiotic, Snubs Sarepta's DMD Drug; Moderna Gets Fast Track Designation For Zika Vaccine",2019-08-20 07:33:00-04:00,ZTS,negative
1412133.0,Shares of several healthcare companies are trading higher as optimism increased for a resolution to the US-China trade war.,2019-08-19 12:31:00-04:00,ZTS,positive
1412134.0,"Shares of healthcare companies are trading higher as US markets rebound from recent weakness following a yield curve inversion, which caused recession fears. Trump also recently announced the US would delay China tariffs, renewing hopes of a trade deal.",2019-08-16 13:27:00-04:00,ZTS,negative
1412135.0,ï»¿Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products.,2019-08-13 11:53:00-04:00,ZTS,positive
1412136.0,"SunTrust Robinson Humphrey Maintains Hold on Zoetis, Raises Price Target to $130",2019-08-13 08:50:00-04:00,ZTS,neutral
1412137.0,A List Of Stocks Reaching New 52-Week Highs,2019-08-09 10:29:00-04:00,ZTS,positive
1412138.0,"The Daily Biotech Pulse: Vascepa Delay Sends Amarin Reeling, Eidos Jumps On Buyout Offer, Nektar's Bitter Q2",2019-08-09 07:19:00-04:00,ZTS,negative
1412139.0,Stocks That Set New 52-Week Highs Thursday,2019-08-08 12:19:00-04:00,ZTS,neutral
1412140.0,"The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",2019-08-07 07:34:00-04:00,ZTS,neutral
1412141.0,85 Biggest Movers From Yesterday,2019-08-07 05:39:00-04:00,ZTS,neutral
1412142.0,68 Stocks Moving In Tuesday's Mid-Day Session,2019-08-06 13:55:00-04:00,ZTS,neutral
1412143.0,New 52-Week-High Achievers For Tuesday Morning,2019-08-06 10:23:00-04:00,ZTS,neutral
1412144.0,Zoetis shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY19 EPS and sales guidance.,2019-08-06 09:44:00-04:00,ZTS,positive
1412145.0,"Zoetis Reports Q2 Earnings Beat, Raises Guidance",2019-08-06 08:32:00-04:00,ZTS,neutral
1412146.0,"The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering",2019-08-06 07:22:00-04:00,ZTS,positive
1412147.0,"Zoetis Raises FY19 Guidance: Adj. EPS From $3.42-$3.52 To $3.53-$3.60 vs $3.49 Estimate, Sales From $6.1B-$6.225B To $6.175B-$6.275B vs $6.19B Est.",2019-08-06 07:12:00-04:00,ZTS,neutral
1412148.0,"Zoetis Q2 Adj. EPS $0.9 Beats $0.82 Estimate, Sales $1.547B Beat $1.52B Estimate",2019-08-06 07:11:00-04:00,ZTS,neutral
1412149.0,"Earnings Scheduled For August 6, 2019",2019-08-06 04:00:00-04:00,ZTS,neutral
1412150.0,Shares of several drug/pharma/medical equipment companies trading lower given weakness in broader stock market following concerns with China trade tensions.,2019-08-05 12:43:00-04:00,ZTS,negative
1412151.0,Zoetis Will Acquire Platinum Performance,2019-07-22 14:17:00-04:00,ZTS,neutral
1412152.0,"Stifel Nicolaus Maintains Buy on Zoetis, Raises Price Target to $130",2019-07-22 09:39:00-04:00,ZTS,neutral
1412153.0,"Zoetis To Acquire Platinum Performance, A Leading Nutrition-Focused Animal Health Business For Equine And Petcare Markets",2019-07-22 08:35:00-04:00,ZTS,neutral
1412154.0,"Zoetis to Acquires Platinum Performance, Terms Not Disclosed",2019-07-22 08:33:00-04:00,ZTS,neutral
1412155.0,BofA Downgrades Veterinary Medicine Maker Zoetis On Valuation,2019-07-01 12:34:00-04:00,ZTS,neutral
1412156.0,10 Biggest Price Target Changes For Monday,2019-07-01 09:34:00-04:00,ZTS,neutral
1412157.0,"Benzinga's Top Upgrades, Downgrades For July 1, 2019",2019-07-01 09:14:00-04:00,ZTS,positive
1412158.0,"Bank of America Downgrades Zoetis to Neutral, Raises Price Target to $120",2019-07-01 07:30:00-04:00,ZTS,neutral
1412159.0,"The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge",2019-06-20 07:25:00-04:00,ZTS,positive
1412160.0,"The Daily Biotech Pulse: Positive Readouts From Adamas And Ironwood, Sesen Bio To Offer Shares, Stoke Therapeutics Debut",2019-06-19 07:51:00-04:00,ZTS,positive
1412161.0,"Barclays Initiates Coverage On Zoetis with Overweight Rating, Announces $120 Price Target",2019-06-11 07:18:00-04:00,ZTS,negative
1412162.0,"The Daily Biotech Pulse: Takeda Pulls Plug On Amyloidosis Drug Trial, Chiasma Preps For Drug Launch With New CEO Appointment, Orchard Prices Offering",2019-06-06 07:37:00-04:00,ZTS,neutral
1412163.0,"The Daily Biotech Pulse: Curtains Down On ASCO, Rewalk Flies, Eli Lilly's Migraine Drug Approved For Cluster Headache",2019-06-05 07:30:00-04:00,ZTS,positive
1412164.0,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,2019-06-04 13:07:00-04:00,ZTS,positive
1412165.0,"Jim Cramer Gives His Opinion On Wendy's, Exelon And More",2019-06-04 07:35:00-04:00,ZTS,neutral
1412166.0,"BMO Capital Maintains Market Perform on Zoetis Inc. Class A Common Stock, Raises Price Target to $105",2019-05-09 09:07:00-04:00,ZTS,neutral
1412167.0,"Jim Cramer Shares His Thoughts On Cirrus Logic, Chart Industries And More",2019-05-03 07:45:00-04:00,ZTS,positive
1412168.0,Gabelli & Co. Downgrades Zoetis Inc. Class A Common Stock to Hold,2019-05-03 06:50:00-04:00,ZTS,neutral
1412169.0,"Zoetis Sees FY19 Adj. EPS $3.42-$3.52 vs $3.47 Est., Sales $6.10B-$6.225B",2019-05-02 07:26:00-04:00,ZTS,neutral
1412170.0,"Zoetis Q1 Adj. EPS $0.88 Beats $0.79 Estimate, Sales $1.455B Beat $1.45B Estimate",2019-05-02 07:25:00-04:00,ZTS,neutral
1412171.0,"Earnings Scheduled For May 2, 2019",2019-05-02 04:43:00-04:00,ZTS,neutral
1412172.0,"The Daily Biotech Pulse: Recro Restructures, Biotechs Raise Proceeds In Droves, Silk Road, NGM Biopharma To Debut",2019-04-04 07:58:00-04:00,ZTS,neutral
1412173.0,"Credit Suisse Maintains Outperform on Zoetis, Raises Price Target to $112",2019-04-02 09:05:00-04:00,ZTS,positive
1412174.0,"The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial",2019-04-02 07:30:00-04:00,ZTS,neutral
1412175.0,"Barron's Picks And Pans: DowDuPont, Wells Fargo, Zoetis And More",2019-03-30 13:41:00-04:00,ZTS,positive
1412176.0,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback",2019-03-22 08:16:00-04:00,ZTS,negative
1412177.0,"The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering",2019-03-21 07:51:00-04:00,ZTS,negative
1412178.0,"The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company",2019-03-20 07:46:00-04:00,ZTS,negative
1412179.0,"SunTrust Robinson Humphrey Initiates Coverage On Zoetis with Hold Rating, Announces $100 Price Target",2019-03-20 07:08:00-04:00,ZTS,neutral
1412180.0,"The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings",2019-03-05 07:24:00-05:00,ZTS,positive
1412181.0,"Benzinga's Top Upgrades, Downgrades For March 4, 2019",2019-03-04 09:01:00-05:00,ZTS,positive
1412182.0,Stifel Nicolaus Upgrades Zoetis to Buy,2019-03-04 07:10:00-05:00,ZTS,neutral
1412183.0,"BMO Capital Maintains Market Perform on Zoetis, Raises Price Target to $101",2019-02-25 10:11:00-05:00,ZTS,neutral
1412184.0,"Zoetis shares are trading higher after the company reported Q4 EPS of $0.79, beating the $0.77 estimate, and sales of $1.6 billion, beating the $1.52 billion estimate; the company also issued FY19 EPS guidance inline with analyst estimates.",2019-02-14 11:05:00-05:00,ZTS,negative
1412185.0,"JANA 13F Shows Liquidated Stakes In GM, Zoetis",2019-02-14 09:37:00-05:00,ZTS,neutral
1412186.0,"The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial",2019-02-14 07:50:00-05:00,ZTS,negative
1412187.0,"Zoetis Sees FY19 Adj. EPS $3.42-$3.52 vs $3.45 Estimate, Sales $6.175B-$6.3B vs $6.23B Est.",2019-02-14 07:03:00-05:00,ZTS,neutral
1412188.0,"Zoetis Q4 EPS $0.79 Beats $0.77 Estimate, Sales $1.6B Beat $1.52B Estimate",2019-02-14 07:02:00-05:00,ZTS,neutral
1412189.0,"Earnings Scheduled For February 14, 2019",2019-02-14 04:21:00-05:00,ZTS,neutral
1412190.0,Zoetis Q4 Earnings Preview,2019-02-13 13:52:00-05:00,ZTS,neutral
1412191.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",2019-02-10 17:37:00-05:00,ZTS,neutral
1412192.0,UBS Initiates Coverage On Zoetis with Neutral Rating,2019-01-23 08:18:00-05:00,ZTS,neutral
1412193.0,"The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen",2018-12-13 07:56:00-05:00,ZTS,positive
1412194.0,Zoetis Raises Quarterly Dividend From $0.126 To $0.146/Share,2018-12-12 16:27:00-05:00,ZTS,neutral
1412195.0,Zoetis Reports $2B Buyback,2018-12-12 16:22:00-05:00,ZTS,neutral
1412196.0,"Stocks Trading Ex Dividend For Mon., Nov. 19, 2018",2018-11-19 10:13:00-05:00,ZTS,neutral
1412197.0,"Stocks That Will Trade Ex Dividend Mon., Nov. 19, 2018",2018-11-16 10:35:00-05:00,ZTS,neutral
1412198.0,13F From JANA Shows New 32K Share Stake In Zoetis,2018-11-14 09:50:00-05:00,ZTS,positive
1412199.0,Paws Up: The First Pets ETF Is Here,2018-11-07 09:49:00-05:00,ZTS,neutral
1412200.0,"The Daily Biotech Pulse: Illumina Snaps Up Pacific Bioscience, Thumbs Down For Alkermes Depressive Disorder Drug",2018-11-02 08:01:00-04:00,ZTS,negative
1412201.0,Zoetis Raises FY18 Adj. EPS Guidance From $3-$3.10 To $3.08-$3.13 vs $3.07 Estimate,2018-11-01 07:04:00-04:00,ZTS,neutral
1412202.0,"Zoetis Q3 EPS $0.83 Beats $0.77 Estimate, Sales $1.48B Beat $1.45B Estimate",2018-11-01 07:02:00-04:00,ZTS,neutral
1412203.0,"Earnings Scheduled For November 1, 2018",2018-11-01 04:15:00-04:00,ZTS,neutral
1412204.0,"JP Morgan Upgrades Zoetis to Overweight, Raises Price Target to $100",2018-10-15 07:04:00-04:00,ZTS,neutral
1412205.0,"Stocks Which Set New 52-Week High Yesterday, October 3rd",2018-10-04 11:18:00-04:00,ZTS,neutral
1412206.0,Stifel Drops Bullish Zoetis Thesis After 108% Outperformance,2018-08-22 09:40:00-04:00,ZTS,neutral
1412207.0,"Benzinga's Top Upgrades, Downgrades For August 22, 2018",2018-08-22 09:16:00-04:00,ZTS,positive
1412208.0,Stifel Nicolaus Downgrades Zoetis to Hold,2018-08-22 07:06:00-04:00,ZTS,neutral
1412209.0,10 Biggest Price Target Changes For Tuesday,2018-08-14 10:01:00-04:00,ZTS,neutral
1412210.0,"Argus Maintains Buy on Zoetis, Raises Price Target to $103",2018-08-14 07:38:00-04:00,ZTS,neutral
1412211.0,"Stocks Which Set New 52-Week High Yesterday, August 9th",2018-08-10 10:03:00-04:00,ZTS,neutral
1412212.0,"Stocks That Made New 52-Week Highs So Far Today Include: Nike, Becton, Cintas, Exelon, Amazon, United Continental, Michael Kors, Target, Medtronic, W.W. Grainger, Ross Stores, Zoetis, Robert Half, IHS Markit, VF, Flowserv, Verisk Analytics, aApple",2018-08-09 11:14:00-04:00,ZTS,positive
1412213.0,"Stocks Which Set New 52-Week High Yesterday, August 8th",2018-08-09 11:03:00-04:00,ZTS,neutral
1412214.0,"The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings",2018-08-09 08:39:00-04:00,ZTS,positive
1412215.0,"Stocks That Made New 52-Week Highs So Far Today Include: Medtronic, Amazon, Pfizer, AES, W.W. Grainger, Centene, Chipotle, Emerson Electric, Zoetis, Michael Kors, United Continental, VF, Aetna, Ross Stores, and UnitedHealth Group",2018-08-08 12:03:00-04:00,ZTS,positive
1412216.0,"Stocks Which Set New 52-Week High Yesterday, August 7th",2018-08-08 11:01:00-04:00,ZTS,neutral
1412217.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,ZTS,positive
1412218.0,"Stocks That Made New 52-Week Highs Earlier Today Include: SL Green Realty, Verisk Analytics, Medtronics, Pfizer, Conoco Phillips, Archer-Daniels, Eli Lilly, Merck, Phillips 66, Costco, Advance Auto Parts, Norfolk Southern, CSX, Zoetis, Apple, and Disney",2018-08-07 11:49:00-04:00,ZTS,neutral
1412219.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,ZTS,neutral
1412220.0,"Stocks Which Set New 52-Week Highs Friday, August 3rd",2018-08-06 13:02:00-04:00,ZTS,neutral
1412221.0,"Stocks Which Set New 52-Week High Yesterday, August 2nd",2018-08-03 11:16:00-04:00,ZTS,neutral
1412222.0,"Stifel Nicolaus Maintains Buy on Zoetis, Raises Price Target to $95",2018-08-03 08:08:00-04:00,ZTS,neutral
1412223.0,"The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings",2018-08-03 07:52:00-04:00,ZTS,neutral
1412224.0,"Morgan Stanley Maintains Equal-Weight on Zoetis, Raises Price Target to $92",2018-08-03 07:32:00-04:00,ZTS,neutral
1412225.0,"Stocks That Made New 52 Week Highs So Far Today Include: PerkinElmer, Eli Lilly, Zoetis, Apple, Simon Property Group, Global Payments, and Church & Dwight",2018-08-02 11:09:00-04:00,ZTS,neutral
1412226.0,"The Daily Biotech Pulse: Denali's Parkinson's Candidate Clears Early-Stage Trials, Dexcom's Strong Quarter",2018-08-02 08:54:00-04:00,ZTS,positive
1412227.0,"Zoetis Narrows FY18 Guidance: Adj. EPS From $2.96-$3.10 To $3-$3.10 vs $3.06 Estimate, Sales From $5.675B-$5.8B To $5.7B-$5.8B vs $5.74B Est.",2018-08-02 07:06:00-04:00,ZTS,neutral
1412228.0,"Zoetis Q2 EPS $0.77 Beats $0.70 Estimate, Sales $1.415B Beat $1.38B Estimate",2018-08-02 07:05:00-04:00,ZTS,neutral
1412229.0,"Earnings Scheduled For August 2, 2018",2018-08-02 04:48:00-04:00,ZTS,neutral
1412230.0,Zoetis Q2 Earnings Preview,2018-08-01 15:16:00-04:00,ZTS,neutral
1412231.0,"Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial",2018-08-01 09:01:00-04:00,ZTS,negative
1412232.0,Zoetis Files S-3ASR For A Mixed Shelf Offering,2018-07-31 13:28:00-04:00,ZTS,neutral
1412233.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs",2018-07-28 14:04:00-04:00,ZTS,neutral
1412234.0,"Zoetis, Abaxis Receive Hart-Scott-Rodino Antitrust Clearance For Deal",2018-07-06 08:00:00-04:00,ZTS,neutral
1412235.0,Hearing Zoetis Deal For Abaxis Has Been Challenged By Shareholder,2018-06-27 17:27:00-04:00,ZTS,negative
1412236.0,"Stocks That Made New 52-Week Highs Today Include: Electronic Arts, Intuit, NetApp, Netflix, Republic Services, VeriSign, Union Pacific, Zoetis, Twenty-First Century Fox, Edward Lifesciences, Ansys, and Advance Auto Parts",2018-06-15 13:58:00-04:00,ZTS,neutral
1412237.0,"Stocks That Made New 52 Week Highs Today Include: Zoetis, Fortive, VeriSign, CF Industries, Ansys, Facebook, IDEXX, Fiserv, Global Payments, CA, Akamai, AES, NVIDIA, Align Tech, and Adobe",2018-06-14 15:51:00-04:00,ZTS,neutral
1412238.0,"Regeneron, Zoetis Report Collaboration To Research Antibody Therapies For Use In Animal Health",2018-06-06 07:03:00-04:00,ZTS,neutral
1412239.0,"Benzinga's Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More",2018-05-17 08:27:00-04:00,ZTS,neutral
1412240.0,41 Biggest Movers From Yesterday,2018-05-17 04:32:00-04:00,ZTS,neutral
1412241.0,Mid-Afternoon Market Update: Blink Charging Rises After Q1 Results; Purple Innovation Shares Slide,2018-05-16 14:30:00-04:00,ZTS,positive
1412242.0,40 Stocks Moving In Wednesday's Mid-Day Session,2018-05-16 12:39:00-04:00,ZTS,neutral
1412243.0,Mid-Day Market Update: Abaxis Climbs On Acquisition News; Evolus Shares Plunge,2018-05-16 12:22:00-04:00,ZTS,positive
1412244.0,Mid-Morning Market Update: Markets Edge Higher; Macy's Tops Q1 Estimates,2018-05-16 10:15:00-04:00,ZTS,positive
1412245.0,Zoetis To Buy Abaxis In $2 Billion Deal,2018-05-16 08:51:00-04:00,ZTS,neutral
1412246.0,26 Stocks Moving In Wednesday's Pre-Market Session,2018-05-16 08:14:00-04:00,ZTS,neutral
1412247.0,"A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Housing Starts, Industrial Production Data",2018-05-16 07:38:00-04:00,ZTS,neutral
1412248.0,Zoetis to Acquire Abaxis for $83/Share in Cash,2018-05-16 07:19:00-04:00,ZTS,neutral
1412249.0,Anatara Lifesciences Announces Exclusive Global License Agreement with Zoetis,2018-05-15 03:56:00-04:00,ZTS,positive
1412250.0,"Zoetis Sees FY18 EPS $2.96-$3.10 vs $3.05 Est., Sales $5.675-$5.8B vs $5.74B Est.",2018-05-02 07:02:00-04:00,ZTS,neutral
1412251.0,"Zoetis Q1 EPS $0.75 Beats $0.69 Estimate, Sales $1.4B Beat $1.35B Estimate",2018-05-02 07:01:00-04:00,ZTS,neutral
1412252.0,"Earnings Scheduled For May 2, 2018",2018-05-02 05:54:00-04:00,ZTS,neutral
1412253.0,Morgan Stanley: 11 High-Conviction Stocks To Watch This Earnings Season,2018-04-22 16:43:00-04:00,ZTS,neutral
1412254.0,Zoetis Shares Reach New 52-Week High of $85.74,2018-04-17 15:17:00-04:00,ZTS,positive
1412255.0,"Stocks That Made New 52 Wk Highs Include Xylem, Zoetis, Marathon Petroleum, and Roper Technologies; New 52 Wk Lows For Procter & Gamble, Kimberly-Clark, Campbell's Soup, GE, and General Mills",2018-03-21 12:33:00-04:00,ZTS,negative
1412256.0,Zoetis Downgraded As Valuation Approaches Morgan Stanley's Price Target,2018-03-19 10:59:00-04:00,ZTS,neutral
1412257.0,"Benzinga's Top Upgrades, Downgrades For March 19, 2018",2018-03-19 09:11:00-04:00,ZTS,positive
1412258.0,Morgan Stanley Downgrades Zoetis to Equal-Weight,2018-03-19 07:27:00-04:00,ZTS,neutral
1412259.0,"Stocks That Made New 52-Wk Highs Earlier Include: Accenture, Raytheon, PNC, M&T Bank, Comerica, Zions Bancorp, Moody's, SunTrust Banks, Fortive, Zoetis, Red Hat, Digital Realty Trust, Cognizant, Adobe, and Salesforce",2018-02-21 12:09:00-05:00,ZTS,positive
1412260.0,"Stocks That Made New 52-Wk Highs Earlier Today Include: Moody's, Adobe, Cognizant, Zoetis, Salesforce, NVIDIA, Red Hat, CSRA, Intuit, Coty, Garmin, Global Payments, and Ansys",2018-02-20 15:01:00-05:00,ZTS,neutral
1412261.0,"Zoetis Sees FY18 Adj. EPS $2.96-$3.10 vs $2.98 Est., Sales $5.675B-$5.8B vs $5.61B Est.",2018-02-15 07:04:00-05:00,ZTS,neutral
1412262.0,"Zoetis Reports Q4 Adj. EPS $0.69 vs $0.66 Est., Sales $1.5B vs $1.4B Est.",2018-02-15 07:04:00-05:00,ZTS,neutral
1412263.0,"Earnings Scheduled For February 15, 2018",2018-02-15 04:12:00-05:00,ZTS,neutral
1412264.0,Zoetis 8-K Shows Expectation For Net Reduction Not Exceeding $350M In Q4 GAAP Net Income Related To Repatriation Following Tax Cuts And Jobs Act,2018-01-08 08:22:00-05:00,ZTS,negative
1412265.0,Zoetis Spikes to High of $73.08 on Volume; Activity in Jan 72.5 Call,2017-12-20 12:58:00-05:00,ZTS,neutral
1412266.0,Zoetis Launches Vanguard CIV H3N2/H3N8 Vaccine for Canine Influenza Virus,2017-12-12 08:09:00-05:00,ZTS,neutral
1412267.0,Zoetis Raises Qtr. Dividend From $.105/Share To $.0126/Share,2017-12-11 16:23:00-05:00,ZTS,neutral
1412268.0,Analyst: Zoetis Deserves To Trade At A Premium,2017-11-29 10:52:00-05:00,ZTS,neutral
1412269.0,"Benzinga's Top Upgrades, Downgrades For November 29, 2017",2017-11-29 09:11:00-05:00,ZTS,positive
1412270.0,Morgan Stanley Upgrades Zoetis to Overweight,2017-11-29 06:56:00-05:00,ZTS,negative
1412271.0,UBS Downgrades Zoetis from Buy to Neutral,2017-11-24 08:22:00-05:00,ZTS,neutral
1412272.0,"Zoetis Sees FY17 Sales $5.225-$5.275B vs $5.2B Est., Adj. EPS $2.34-$2.39 vs $2.34 Est.",2017-11-02 07:04:00-04:00,ZTS,neutral
1412273.0,"Zoetis Reports Q3 Adj. EPS $0.65 vs $0.62 Est., Sales $1.3B vs $1.32B Est.",2017-11-02 07:03:00-04:00,ZTS,neutral
1412274.0,"Earnings Scheduled For November 2, 2017",2017-11-02 05:08:00-04:00,ZTS,neutral
1412275.0,Zoetis Shares Spike 0.5% Higher Following Mention On CNBC's 'Fast Money Halftime Report' by Karen Firestone,2017-10-30 12:54:00-04:00,ZTS,positive
1412276.0,"Cantor Fitzgerald Global Healthcare Conference Continues Today, Presenters Include:  Innoviva, Puma Biotech, Magellan Health, TherapeuticsMD, Zoetis, Aurinia Pharma and Celgene",2017-09-26 08:36:00-04:00,ZTS,neutral
1412277.0,VCA Announces Its VCA Animal Hospitals Unit To Partner With Zoetis Related To Successful Clinical Study On Clavamox Chewable Antibiotic Tablets,2017-08-14 11:31:00-04:00,ZTS,positive
1412278.0,"Zoetis Sees FY17 Sales $5.15-$5.25B vs $5.19B Est., Adj. EPS $2.30-$2.37 vs $2.33 Est.",2017-08-08 07:29:00-04:00,ZTS,neutral
1412279.0,"Zoetis  Reports Q2 Adj. EPS $0.53 vs $0.53 Est., Sales $1.3B vs $1.27B Est.",2017-08-08 07:29:00-04:00,ZTS,neutral
1412280.0,"Earnings Scheduled For August 8, 2017",2017-08-08 04:35:00-04:00,ZTS,neutral
1412281.0,Watch These 7 Huge Call Purchases In Tuesday Trade,2017-08-08 04:04:00-04:00,ZTS,positive
1412282.0,Zoetis Option Alert: Aug 18 $60.5 Calls Sweep (30) at the Ask: 597 @ $1.996 vs 0 OI; Ref=$61.67,2017-08-07 14:41:00-04:00,ZTS,positive
1412283.0,Zoetis Investors May Need Patience To See Bull Thesis Play Out,2017-07-26 11:08:00-04:00,ZTS,positive
1412284.0,"Benzinga's Top Upgrades, Downgrades For July 26, 2017",2017-07-26 09:25:00-04:00,ZTS,positive
1412285.0,The Market In 5 Minutes,2017-07-26 09:03:00-04:00,ZTS,neutral
1412286.0,Deutsche Bank Downgrades Zoetis to Hold,2017-07-26 06:19:00-04:00,ZTS,neutral
1412288.0,"Cantor Fitzgerald Initiates Coverage On Zoetis with Overweight Rating, Announces $75.00 Price Target",2017-06-16 06:34:00-04:00,ZTS,negative
1412290.0,"Looking For A Better Entry Point, BMO Downgrades Zoetis Shares",2017-06-13 14:39:00-04:00,ZTS,positive
1412291.0,"Benzinga's Top Upgrades, Downgrades For June 13, 2017",2017-06-13 09:55:00-04:00,ZTS,positive
1412292.0,BMO Capital Downgrades Zoetis to Market Perform,2017-06-13 07:18:00-04:00,ZTS,neutral
1412296.0,"Benzinga's Top Upgrades, Downgrades For May 26, 2017",2017-05-26 09:31:00-04:00,ZTS,positive
1412297.0,"CL King Initiates Coverage On Zoetis with Buy Rating, Announces $71.00 Price Target",2017-05-26 08:37:00-04:00,ZTS,neutral
1412298.0,Watch These 7 Huge Put Purchases In Friday Trade,2017-05-26 05:17:00-04:00,ZTS,positive
1412299.0,Benzinga's Option Alert Recap From May 25,2017-05-25 16:31:00-04:00,ZTS,positive
1412300.0,Option Alert: Zoetis Jan18 60.0 Puts Sweep: 623 @  ASK  $2.55: 736 traded vs 128 OI:  Earnings 8/3 Before Open (est)  $62.38 Ref,2017-05-25 14:34:00-04:00,ZTS,positive
1412301.0,"Zoetis Announces Will Receive $14.4M Grant from Bill & Melinda Gates Foundation Over Next 3 Years for Development of Veterinary Diagnostic Networks, Animal Health Infrastructure in Ethiopia, Nigeria, Uganda",2017-05-08 12:02:00-04:00,ZTS,positive
1412302.0,"Zoetis Reaffirms FY17 Outlook: Adj. EPS $2.26-$2.36 vs $2.32 Est., Sales $5.1B-$5.225B",2017-05-04 07:15:00-04:00,ZTS,neutral
1412303.0,"Zoetis Reports Q1 EPS $0.48, Inline, Sales $1.2B vs $1.19B Est.",2017-05-04 07:14:00-04:00,ZTS,neutral
1412304.0,Watch These 8 Huge Call Purchases In Friday Trade,2017-04-28 04:15:00-04:00,ZTS,positive
1412305.0,Benzinga's Option Alert Recap From April 27,2017-04-27 17:01:00-04:00,ZTS,positive
1412306.0,Zoetis Shares Up 1.3% As Animal Pharm Reported That Zoetis Received Authorization For First mAB for Vet Use In Europe,2017-04-27 12:06:00-04:00,ZTS,positive
1412307.0,Option Alert: Zoetis May 57.5 Calls Sweep: 731 @  ASK  $0.75: 731 traded vs 33 OI:  Earnings 5/4 Before Open  $56.26 Ref,2017-04-27 12:03:00-04:00,ZTS,positive
1412308.0,Option Alert: Zoetis May 5th 56.0 Calls Sweep: 2801 @  ASK  $0.95: 2801 traded vs 28 OI:  Earnings 5/4 Before Open  $55.76 Ref,2017-04-27 10:14:00-04:00,ZTS,positive
1412309.0,Zoetis Reports Received EC Market Authorization for Cytopoint,2017-04-26 16:30:00-04:00,ZTS,neutral
1412310.0,10 Biggest Mid-Day Gainers For Thursday,2017-04-13 13:48:00-04:00,ZTS,neutral
1412311.0,"Zoetis Reports Purchase of Nexvet Biopharma for $6.72/Share, or ~$85M Deal",2017-04-13 09:24:00-04:00,ZTS,neutral
1412312.0,Zoetis Drops to Low of $53.72 on Volume,2017-03-29 14:08:00-04:00,ZTS,negative
1412313.0,"Benzinga's Top Upgrades, Downgrades For March 16, 2017",2017-03-16 09:30:00-04:00,ZTS,positive
1412314.0,"Craig-Hallum Initiates Coverage On Zoetis With Buy, Announces $65 Price Target",2017-03-16 06:14:00-04:00,ZTS,neutral
1412315.0,"Cowen Annual Healthcare Conference Begins Today; Presenters Include Insulet, PARAXEL, Zoetis, Alexion, Bristol-Myers, Acadia, Alnylam, Axovant, Ardelyx, Aurinia Pharma, And Puma Biotech",2017-03-06 08:39:00-05:00,ZTS,neutral
1412316.0,Q4 2016 Real-Time Call Brief,2017-02-16 09:41:00-05:00,ZTS,neutral
1412317.0,"Zoetis Sees FY17 Revenue $5.1-$5.225B vs. $5.18B, Adj. EPS $2.26-$2.36 vs. $2.33 Est.",2017-02-16 07:01:00-05:00,ZTS,neutral
1412318.0,"Zoetis Reports Q4 Adj. EPS $0.47 vs. $0.45 Est., Rev. $1.3B vs. $1.27B Est.",2017-02-16 07:00:00-05:00,ZTS,neutral
1412319.0,Zoetis Reports Received EC Approval for Stronghold Plus,2017-02-15 16:30:00-05:00,ZTS,positive
1412320.0,Watch These 8 Huge Call Purchases In Monday Trade,2017-01-23 04:03:00-05:00,ZTS,positive
1412321.0,Option Alert: Zoetis Jan 27th 53.5 Calls Sweep: 1425 @  ASK  $1.20: 1425 traded vs 68 OI:  Earnings 2/16 Before Open  $53.89 Ref,2017-01-20 09:35:00-05:00,ZTS,positive
1412322.0,Wall Street's M&A Chatter From January 18,2017-01-19 06:48:00-05:00,ZTS,neutral
1412323.0,"Handelsblatt Says Boehringer, 'Setting its sights on Zoetis' Due To Attractive Nature Of Animal Health Sector",2017-01-18 10:10:00-05:00,ZTS,positive
1412324.0,Zoetis Spikes to High of $54.01 on Volume,2017-01-18 10:08:00-05:00,ZTS,neutral
1412325.0,"JP Morgan Healtchare Conf. Continues Today; Presenters Include Novocure, Zoetis, Oxford Immunotec, Enanta, Irhythm Tech, Walgreen's, & Mylan",2017-01-11 08:34:00-05:00,ZTS,positive
1412326.0,Zoetis Receives USDA License For CYTOPOINT,2016-12-21 16:30:00-05:00,ZTS,neutral
1412327.0,"Deutsche Bank Initiates Coverage On Zoetis at Buy, Announces $62.00 Target",2016-12-20 06:36:00-05:00,ZTS,neutral
1412328.0,Jefferies' 2017 Global Pharma Outlook,2016-12-19 10:56:00-05:00,ZTS,neutral
1412329.0,7 Biggest Price Target Changes For Thursday,2016-12-15 09:45:00-05:00,ZTS,neutral
1412330.0,"Benzinga's Top Upgrades, Downgrades For December 15, 2016",2016-12-15 09:22:00-05:00,ZTS,positive
1412331.0,The Market In 5 Minutes: Interest Rate Hike Finally Arrives,2016-12-15 09:00:00-05:00,ZTS,positive
1412332.0,"PiperJaffray Reinstates Overweight on Zoetis, Announces $61.00 Target",2016-12-15 08:03:00-05:00,ZTS,negative
1412333.0,"Cowen & Co. Upgrades Zoetis to Outperform, Raises Target to $60.00",2016-12-15 05:46:00-05:00,ZTS,neutral
1412334.0,Bill Ackman's Pershing Square Issues Q3 Shareholder Letter,2016-12-07 16:11:00-05:00,ZTS,neutral
1412335.0,Zoetis Reports  $1.5 Billion Share Repurchase Program,2016-12-06 16:15:00-05:00,ZTS,positive
1412336.0,13F from Bill Ackman's Pershing Square Shows Reduced Stake in Zoetis from ~21.17M Shares to ~2.71M Shares,2016-11-14 17:31:00-05:00,ZTS,positive
1412337.0,Watch These 5 Huge Put Purchases In Friday Trade,2016-11-11 02:32:00-05:00,ZTS,positive
1412338.0,Pershing Square No Longer Holds A Position In Zoetis,2016-11-10 14:01:00-05:00,ZTS,negative
1412339.0,Pershing Square Confirms To Benzinga That Bill Ackman Announced This Morning That He Sold His Stake In Zoetis On Pershing Square Holdings Quarterly Investor Call,2016-11-10 12:33:00-05:00,ZTS,neutral
1412340.0,Option Alert: ZTS Fri 11/11 50.5 Puts (Wkly) Sweep: 500 @  ASK  $0.40: 500 traded vs 304 OI:  Earnings 2/16 Before Open (est)  $50.71 Ref,2016-11-10 12:06:00-05:00,ZTS,positive
1412341.0,Zoetis Shares Dipping Lower as Hearing Bill Ackman May Have Liquidated Position,2016-11-10 12:06:00-05:00,ZTS,neutral
1412342.0,Zoetis Raises FY17 Adj. EPS Outlook from $2.24-$2.38 to $2.28-$2.38 vs $2.32 Est.,2016-11-02 07:03:00-04:00,ZTS,neutral
1412343.0,"UPDATE: Zoetis Raises FY16 Adj. EPS Outlook from $1.86-$1.93 to $1.91-$1.96 vs $1.91 Est., Sales $4.85B-$4.9B vs $4.88B Est.",2016-11-02 07:03:00-04:00,ZTS,neutral
1412344.0,"Zoetis Raises FY16, FY17 Outlooks",2016-11-02 07:02:00-04:00,ZTS,neutral
1412345.0,"Zoetis Reports Q3 Adj. EPS $0.52 vs $0.47 Est., Sales $1.2B vs $1.22B Est.",2016-11-02 07:01:00-04:00,ZTS,neutral
1412346.0,10 Stocks That Plummeted The Past Three Days On Increasing Volume,2016-11-02 06:49:00-04:00,ZTS,neutral
1412347.0,"10 Notable Stocks Trading Ex-Dividend Tuesday, November 1",2016-10-31 12:00:00-04:00,ZTS,neutral
1412348.0,"VCA Shares Down 6% Following Q3 Miss; Other Animal Health Stocks Moving in Sympathy: Zoetis Down ~1.8%, Aratana Therapeutics Down 0.7%, Parnell Pharma Down 2%, Phibro Animal Health Up 0.3%",2016-10-26 09:46:00-04:00,ZTS,positive
1412349.0,Benzinga's Top Initiations,2016-09-29 09:12:00-04:00,ZTS,positive
1412350.0,Bank of America Initiates Coverage on Zoetis at Buy,2016-09-29 08:15:00-04:00,ZTS,neutral
1412351.0,Zoetis Capitalizing On Lack Of Competition In Generic Animal Drug Competition,2016-09-09 10:29:00-04:00,ZTS,negative
1412352.0,"Credit Suisse Focus List Additions: PGR, SLCA, ZTS",2016-09-07 07:10:00-04:00,ZTS,positive
1412353.0,"Barron's Picks And Pans: Good News For Barnes & Noble And Zoetis, But 'Beware The Bear'",2016-09-04 10:48:00-04:00,ZTS,positive
1412354.0,A Cascade Of Corporate Exec Hires This Week,2016-08-25 14:23:00-04:00,ZTS,neutral
1412355.0,Zoetis Names Glenn David as CFO,2016-08-22 04:08:00-04:00,ZTS,neutral
1412356.0,The Least Popular Stocks This 13F Season,2016-08-16 12:08:00-04:00,ZTS,negative
1412357.0,13F from Ackman's Pershing Square Shows Reduced Stake in Zoetis from ~41.8M Shares to ~21.17M Shares,2016-08-15 16:28:00-04:00,ZTS,positive
1412358.0,Zoetis Reports Deal to Buy Scandinavian Micro Biodevices for $80M,2016-08-08 08:08:00-04:00,ZTS,neutral
1412359.0,20 Biggest Mid-Day Gainers For Wednesday,2016-08-03 12:37:00-04:00,ZTS,neutral
1412360.0,20 Stocks Moving In Wednesday's Pre-Market Session,2016-08-03 08:25:00-04:00,ZTS,neutral
1412361.0,"UPDATE: Zoetis Raises FY16 Sales Outlook from $1.83-$1.90 to $1.86-$1.93 vs $1.87 Est., Sales from $4.775B-$4.875B to $4.8B-$4.9B vs $4.85B Est.",2016-08-03 07:04:00-04:00,ZTS,neutral
1412362.0,Zoetis Raises FY Outlook,2016-08-03 07:03:00-04:00,ZTS,neutral
1412363.0,"Zoetis Reports Q2 Adj. EPS $0.49 vs $0.44 Est., Sales $1.2B vs $1.17B Est.",2016-08-03 07:03:00-04:00,ZTS,neutral
1412364.0,5 Pharmaceutical Price Target Raises From Jefferies,2016-06-14 15:13:00-04:00,ZTS,neutral
1412365.0,"Citi Downgrades Zoetis, Cites Valuation",2016-06-10 09:39:00-04:00,ZTS,neutral
1412366.0,5 Largest Price Target Changes For Friday,2016-06-10 09:31:00-04:00,ZTS,neutral
1412367.0,The Market In 5 Minutes: Gotta Get Down On Friday,2016-06-10 08:46:00-04:00,ZTS,neutral
1412368.0,"Citigroup Downgrades Zoetis to Neutral, Raises PT to $50.00",2016-06-10 06:26:00-04:00,ZTS,neutral
1412369.0,"Stifel Initiates Coverage On Zoetis, Sets $58 Target",2016-06-01 12:16:00-04:00,ZTS,neutral
1412370.0,Benzinga's Top Initiations,2016-06-01 09:45:00-04:00,ZTS,positive
1412371.0,"Stifel Nicolaus Initiates Coverage on Zoetis at Buy, Announces $58.00 PT",2016-06-01 04:49:00-04:00,ZTS,neutral
1412372.0,"Jefferies Updates Price Targets In Global Pharma, Sees 'Rich Catalyst Environment' Ahead",2016-05-11 13:05:00-04:00,ZTS,positive
1412373.0,Amended 13D Filing from Bill Ackman's Pershing Square Shows Reduced Stake in Zoetis to 5%,2016-05-10 17:58:00-04:00,ZTS,neutral
1412374.0,Zoetis Shares Fall After-Hours on NY Times Report that Bill Ackman's Pershing Square was Selling 16.85M Shares,2016-05-09 18:11:00-04:00,ZTS,positive
1412375.0,"Goldman Downgrades Zoetis, Sees Limited Upside",2016-05-06 12:07:00-04:00,ZTS,negative
1412376.0,"Goldman Sachs Downgrades Zoetis to Sell, Raises PT to $48.00",2016-05-06 04:26:00-04:00,ZTS,neutral
1412377.0,"Zoetis Sees FY16 Sales $5.075B-$5.275B vs $5.06B Est., Adj. EPS $2.24-$2.38 vs $2.26 Est.",2016-05-04 07:08:00-04:00,ZTS,neutral
1412378.0,"Zoetis Raises FY16 Sales Outlook to $4.775B-$4.875B vs $4.75B Est., Adj. EPS $1.83-$1.90 vs $1.79 Est.",2016-05-04 07:08:00-04:00,ZTS,neutral
1412379.0,"Zoetis Reports Q1 Adj. EPS $0.48 vs $0.41 Est., Sales $1.2B vs $1.1B Est.",2016-05-04 07:07:00-04:00,ZTS,neutral
1412380.0,"Earnings Scheduled For May 4, 2016",2016-05-04 04:44:00-04:00,ZTS,neutral
1412381.0,"Pershing Square Says It's 'Pleased' With Zoetis' Progress, Discloses Unchanged 8.4% Stake",2016-04-25 10:44:00-04:00,ZTS,positive
1412382.0,Zoetis Announces Pershing Square Capital Management would Not be Exercising its Option to have Mr. William Doyle Serve on Company's Board of Directors through 2017 Annual Shareholders Meeting,2016-04-25 06:37:00-04:00,ZTS,neutral
1412383.0,"Lachapelle: If Bayer Expands In Animal Healthcare, Zoetis Is Obvious Choice",2016-04-15 13:05:00-04:00,ZTS,positive
1412384.0,Option Alert: ZTS Jan17 35.0 Puts: 42000 @  Above Ask!  $2.30: 84k traded vs 88k OI:  Earnings 5/3  $42.16 Ref,2016-03-22 09:54:00-04:00,ZTS,positive
1412385.0,Zoetis Receives FDA Approval for SimparicaTM (sarolaner) Chewables,2016-02-25 16:30:00-05:00,ZTS,positive
1412386.0,"BMO Capital Positive On Zoetis, Says Current Price Is Good Entry For Fundamental Players, Expects Co To Hit Or Exceed Upper Bound Guidance In 2016 & 2017",2016-02-17 09:13:00-05:00,ZTS,positive
1412387.0,13F from JANA Shows Liquidated Position in Zoetis,2016-02-16 08:23:00-05:00,ZTS,neutral
1412388.0,Zoetis Sees Full Year 2017 Revenue Guidance to $4.950 - $5.150 Billion and Reaffirms Adjusted Diluted EPS of $2.18 - $2.32,2016-02-16 07:03:00-05:00,ZTS,neutral
1412390.0,"Zoetis Reports Q4 EPS $0.43 vs. Est. $0.39, Rev. $1.3B vs. Est. $1.25B",2016-02-16 07:01:00-05:00,ZTS,neutral
1412391.0,"Earnings Scheduled For February 16, 2016",2016-02-16 04:07:00-05:00,ZTS,neutral
1412392.0,"Credit Suisse Initiates Coverage on Zoetis at Outperform, Announces $58.00 PT",2016-02-03 16:40:00-05:00,ZTS,positive
1412393.0,Zoetis to Sell 55% Stake in Manufacturing Site for $13M,2016-01-14 06:08:00-05:00,ZTS,neutral
1412394.0,UPDATE: Zoetis Cuts FY16 Adj. EPS Outlook by $0.13,2016-01-12 08:01:00-05:00,ZTS,negative
1412395.0,"Zoetis Disappointed with EC News Related to Belgium's Tax Rulings, Implications for Co.; Sees Effective Tax Rate Increased in '16",2016-01-12 08:01:00-05:00,ZTS,positive
1412396.0,Zoetis To Sell Manufacturing Site in India for $29M,2016-01-05 06:10:00-05:00,ZTS,neutral
1412397.0,Next Year Could Be Interesting For Spin-Off ETFs,2015-12-29 09:05:00-05:00,ZTS,positive
1412398.0,"Zoetis Is The Only Publicly-Traded Pure-Play Animal Health, Vaccine Company",2015-12-28 09:32:00-05:00,ZTS,neutral
1412399.0,Zoetis Volume Spike,2015-12-24 10:44:00-05:00,ZTS,neutral
1412400.0,"Zoetis To Divest 2 Manufacturing Sites To Huvepharma, Zoetis Will Receive $40M Cash And Additional Considerations; Expects Transaction To Complete Q1 2016",2015-12-22 08:07:00-05:00,ZTS,neutral
1412401.0,Benzinga's Weekend M&A Chatter,2015-12-20 20:14:00-05:00,ZTS,neutral
1412402.0,Reuters Reports Bayer Could be Viewing Zoetis as Potential Takeover Target,2015-12-18 11:25:00-05:00,ZTS,neutral
1412403.0,Zoetis Increases Qtr. Dividend From $0.0825 To $0.095/Share,2015-12-16 16:30:00-05:00,ZTS,neutral
1412404.0,Major Pharma Group Outlook In 2016: Fundamentals To Outweigh Political Headwinds,2015-12-12 14:05:00-05:00,ZTS,neutral
1412405.0,Dan Nathan Sees Unusual Options Activity In Zoetis,2015-12-01 06:18:00-05:00,ZTS,neutral
1412406.0,Pfizer Delaying Decision to Split -NY Times Deal Book,2015-11-24 12:23:00-05:00,ZTS,neutral
1412407.0,JANA Shows New 3.89M Share Stake in Zoetis,2015-11-16 15:44:00-05:00,ZTS,positive
1412408.0,"Zoetis Sees FY17 Adj. EPS $2.24-$2.38, Sales $5.025B-$5.225B",2015-11-03 07:02:00-05:00,ZTS,neutral
1412409.0,"Zoetis Sees FY16 SAdj. EPS $1.84-$1.94 vs $1.90 Est., Sales $4.75B-$4.875B vs $4.78B Est.",2015-11-03 07:02:00-05:00,ZTS,neutral
1412410.0,"Zoetis Updates FY15 Outlook: Adj. EPS $1.70-$1.74 vs $1.66 Est., Sales $4.7B-$4.75B vs $4.76B Est.",2015-11-03 07:01:00-05:00,ZTS,neutral
1412411.0,"Zoetis Reports Q3 Adj. EPS $0.50 vs $0.40 Est., Sales $1.2B vs $1.18B Est.",2015-11-03 07:00:00-05:00,ZTS,neutral
1412412.0,"Earnings Scheduled For November 3, 2015",2015-11-03 04:20:00-05:00,ZTS,neutral
1412413.0,Permira Funds To Sell PHARMAQ To Zoetis For $765M,2015-11-02 17:09:00-05:00,ZTS,neutral
1412414.0,Zoetis Announces Will Purchase PHARMAQ for $765M,2015-11-02 17:02:00-05:00,ZTS,neutral
1412416.0,"Shares Of Zoetis Climbing Over Past 25 Minutes, Now Trading At $41.02/Share",2015-10-21 13:46:00-04:00,ZTS,positive
1412417.0,"For Zoetis, It's All About Margins And M&A",2015-09-28 11:12:00-04:00,ZTS,neutral
1412418.0,"UPDATE: Zoetis Shares Spike ~$1.50 Over Last Few Mins, Stock Now Up 2.9% for Session",2015-09-17 10:32:00-04:00,ZTS,positive
1412419.0,"Zoetis to Participate at 2015 Morgan Stanley Global Healthcare Conference on Friday, September 18, in New York",2015-09-17 10:31:00-04:00,ZTS,neutral
1412420.0,Option Alert: $ZTS Oct $46 Call; 1000 Contracts @Ask @$1.30; Now $45.04,2015-09-17 10:27:00-04:00,ZTS,positive
1412421.0,BMO Capital Upgrades Zoetis to Outperform,2015-09-11 07:05:00-04:00,ZTS,neutral
1412422.0,"Zoetis, HCA Holdings Shares Halted on Circuit Breaker",2015-08-24 09:47:00-04:00,ZTS,positive
1412423.0,A Look At Bill Ackman's Super-Concentrated Equity Portfolio,2015-08-18 15:51:00-04:00,ZTS,neutral
1412424.0,What Steven Cohen Did With His Wealth In Q2,2015-08-17 16:02:00-04:00,ZTS,positive
1412425.0,William Blair Upgrades Zoetis to Outperform,2015-08-06 07:55:00-04:00,ZTS,neutral
1412426.0,Evercore ISI's Mark Schoenebaum Comments On Zoetis' Q2 Call,2015-08-04 14:58:00-04:00,ZTS,neutral
1412427.0,"Zoetis Reports Q2 Sales $1.2B vs $1.12B Est., Adj. EPS $0.43 vs $0.38 Est.; Sees FY15 Adj. EPS $1.63-$1.68 vs $1.66 Est.",2015-08-04 07:11:00-04:00,ZTS,neutral
1412428.0,Zoetis Given a Conditional License from USDA for Canine Atopic Dermatitis Immunotherapeutic,2015-08-03 16:33:00-04:00,ZTS,neutral
1412430.0,Canaccord Believes Zoetis Could Bid For Idexx Laboratories,2015-06-29 10:15:00-04:00,ZTS,neutral
1412431.0,"Canaccord Believes Zoetis Could Make A Bid For IDEXX, Sees IDXX Shares With Upside Potential Given Buyback Of $10M And CEO Stock Purchasing",2015-06-29 09:09:00-04:00,ZTS,positive
1412432.0,Benzinga's Weekend M&A Chatter,2015-06-28 20:20:00-04:00,ZTS,neutral
1412433.0,10 Movers To Keep An Eye On This Week,2015-06-28 12:55:00-04:00,ZTS,neutral
1412434.0,Mid-Afternoon Market Update: US Stocks Mixed; Micron Technology Shares Fall On Downbeat Results,2015-06-26 15:32:00-04:00,ZTS,positive
1412435.0,Mid-Day Market Update: Nike Jumps On Strong Results; SYNNEX Shares Slide,2015-06-26 12:53:00-04:00,ZTS,positive
1412436.0,BMO Downgrades Zoetis After Valeant Report,2015-06-26 12:36:00-04:00,ZTS,neutral
1412437.0,"Friday's Mid-Day Movers: Micron, Winnebago, Cleveland BioLabs And More",2015-06-26 12:32:00-04:00,ZTS,neutral
1412438.0,Is Bill Ackman Playing Cupid In Valeant's Rumored Attempt To Woo Zoetis?,2015-06-26 12:26:00-04:00,ZTS,positive
1412439.0,Mid-Morning Market Update: Markets Gain; Finish Line Beats Q1 Views,2015-06-26 11:33:00-04:00,ZTS,positive
1412440.0,Valeant-Zoetis Combination Has 'Accretive' Upside,2015-06-26 10:00:00-04:00,ZTS,neutral
1412441.0,Morning Market Losers,2015-06-26 09:48:00-04:00,ZTS,negative
1412442.0,Zoetis Shares Pullback After Open; May be Attributed to Negative Comments by David Faber on CNBC,2015-06-26 09:35:00-04:00,ZTS,negative
1412443.0,US Stock Futures Rise Ahead Of Consumer Sentiment Report,2015-06-26 07:37:00-04:00,ZTS,neutral
1412444.0,Zoetis Eyed For Acquisition By Valeant Pharmaceuticals,2015-06-26 07:03:00-04:00,ZTS,neutral
1412445.0,Dan Nathan Sees Unusual Options Activity In Zoetis,2015-06-26 06:56:00-04:00,ZTS,neutral
1412446.0,"JP Morgan Comments on Potential Combination Of Valeant And Zoetis, Remains Overweight VRX and Neutral on ZTS",2015-06-26 06:10:00-04:00,ZTS,neutral
1412447.0,Must Watch Stocks for Today,2015-06-26 05:05:00-04:00,ZTS,neutral
1412448.0,"Benzinga's M&A Chatter for Thursday June 25, 2015",2015-06-25 18:16:00-04:00,ZTS,neutral
1412449.0,Valeant Made Preliminary Takeover Approach to Zoetis - Sources,2015-06-25 15:57:00-04:00,ZTS,neutral
1412450.0,Zoetis CEO Talks Animal Health At William Blair Growth Conference,2015-06-11 12:14:00-04:00,ZTS,positive
1412451.0,Who's The Next Big Pharma Acquisition?,2015-05-29 11:20:00-04:00,ZTS,neutral
1412452.0,Stocks Hitting 52-Week Highs,2015-05-29 10:14:00-04:00,ZTS,neutral
1412453.0,Portfolio Manager Minyi Chen On Why Certain Companies Are Likely M&A Targets,2015-05-18 16:39:00-04:00,ZTS,positive
1412454.0,Bill Ackman's Latest Moves In Health Care & Some Other Positions From Q1,2015-05-16 09:54:00-04:00,ZTS,positive
1412455.0,Affymetrix Acquires Assets of Eureka Genomics Corporation for $15M in Cash,2015-05-14 05:03:00-04:00,ZTS,positive
1412456.0,From Conf Call: Zoetis CEO Says Co to Cut 2000-2500 Jobs in Next 18 Months,2015-05-05 09:33:00-04:00,ZTS,negative
1412457.0,"Zoetis Posts Upbeat Q1 Earnings, But Lowers FY15 Forecast",2015-05-05 09:25:00-04:00,ZTS,negative
1412458.0,From Conf Call: Zoetis CFO Says Shares Buybacks Will Continue to be Part of Co's Plans,2015-05-05 09:24:00-04:00,ZTS,positive
1412459.0,From Zoetis Q1 Earnings Conference Call: Expecting to Reduce Headcount by 2-2.5K Employees Over the Next Year to Year and a Half,2015-05-05 08:51:00-04:00,ZTS,neutral
1412460.0,"Zoetis Sees FY17 Adj. EPS $2.18-$2.32, Sales $4.85B-$5.05B",2015-05-05 07:07:00-04:00,ZTS,neutral
1412461.0,"Zoetis Reports Q1 EPS $0.33 Vs Est $0.37, Sales $1.1B Vs Est $1.11B",2015-05-05 07:00:00-04:00,ZTS,neutral
1412462.0,"Earning & Economic Calendar for Tuesday May 5, 2015",2015-05-05 05:38:00-04:00,ZTS,neutral
1412463.0,Bill Ackman Next Speaker at Sohn Conference,2015-05-04 17:41:00-04:00,ZTS,neutral
1412464.0,No Growth For Zoetis; Analysts Expect Flat YOY Earnings,2015-05-04 13:58:00-04:00,ZTS,positive
1412465.0,"Shares of Zoetis Volatile Here as Bill Ackman Recently Discussing on CNBC in Interview with Scott Wapner, Josh Brown",2015-05-04 12:38:00-04:00,ZTS,positive
1412466.0,"Ira Sohn Conference Live Blog: Movers, Shakers, Hedgie Comments",2015-05-04 12:08:00-04:00,ZTS,positive
1412467.0,Pennsylvania DEP Awards $2.05M in West Nile Virus Grants to 25 Counties -Reuters,2015-05-01 10:40:00-04:00,ZTS,positive
1412468.0,Option Alert: Zoetis October $48 Call; 1786 Contract Trade at Ask @$3.20,2015-04-20 15:00:00-04:00,ZTS,positive
1412469.0,Activist Investors And Insider Buying: A Strong Signal,2015-04-17 14:10:00-04:00,ZTS,positive
1412470.0,Canine Flu Outbreak Reported in Chicago Area -Wall Street Journal,2015-04-15 11:40:00-04:00,ZTS,negative
1412471.0,UPDATE: Filing from Pershing Square on Zoetis Shows Very Slightly Increased Stake in Zoetis from 8.35% as of Feb. 3 to 8.4%,2015-04-13 16:05:00-04:00,ZTS,positive
1412472.0,Amended 13D Filing from Bill Ackman's Pershing Square on Zoetis Just Out,2015-04-13 16:04:00-04:00,ZTS,neutral
1412473.0,Earlier Filing from Zoetis Shows Actavis Chair Paul Bisaro Named to Board; Shares Trading Up ~$0.70,2015-04-13 09:17:00-04:00,ZTS,positive
1412475.0,"Books on Valeant's $9.6B High Yield Bond Near $29B, According to Source -Reuters",2015-03-12 13:12:00-04:00,ZTS,neutral
1412476.0,8 Healthcare Names Cowen & Co Are Talking About,2015-03-10 18:02:00-04:00,ZTS,neutral
1412477.0,Pershing Square Buys 5% Stake In Valeant Pharmaceuticals -Reuters,2015-03-09 12:19:00-04:00,ZTS,neutral
1412478.0,The Zoetis Catalyst Schedule Wall Street Is Watching,2015-02-24 18:23:00-05:00,ZTS,neutral
1412479.0,Evercore ISI Technical Analysis: The 'Single Best Idea',2015-02-23 07:34:00-05:00,ZTS,positive
1412480.0,ValueWalk On What Might Be Pershing Square's 'Big Secret Short',2015-02-19 15:53:00-05:00,ZTS,neutral
1412481.0,"Actavis, NRG Energy, Wal-Mart, Zoetis, Best Buy, Mentioned by ValueWalk as Potential Ackman Shorts",2015-02-19 13:05:00-05:00,ZTS,positive
1412482.0,What Steven Cohen Is Doing With His Personal Wealth,2015-02-18 15:42:00-05:00,ZTS,positive
1412483.0,"Ackman's Pershing Square Scaled Back Allergan, Added To Platform Specialty Products In Q4",2015-02-17 18:17:00-05:00,ZTS,neutral
1412484.0,CORRECTION: 13F Filing from Ackman's Pershing Shows Less Recent Stake in Zoetis Compared to Feb. 4th Filing; More Recent Filing Shows Stake of ~41.82M Shares,2015-02-17 16:52:00-05:00,ZTS,positive
1412485.0,"Bill Ackman Thinks Valeant Is 'Incredibly Disciplined,' And Says He'd Own McDonald's If 3G Capital Was In Charge",2015-02-13 13:06:00-05:00,ZTS,neutral
1412486.0,"JP Morgan Downgrades Zoetis to Neutral, Maintains $48.00 PT",2015-02-13 06:20:00-05:00,ZTS,positive
1412487.0,"Zoetis Flexes Muscles; Has ""Pipeline Power,"" Says Barclays",2015-02-12 11:29:00-05:00,ZTS,neutral
1412488.0,Stocks Hitting 52-Week Highs,2015-02-11 10:14:00-05:00,ZTS,neutral
1412489.0,Morning Market Gainers,2015-02-11 09:48:00-05:00,ZTS,neutral
1412490.0,UPDATE: Zoetis Shares Rise On Upbeat Earnings,2015-02-11 08:16:00-05:00,ZTS,positive
1412491.0,"Zoetis Reports Q4 Adj. EPS $0.40 vs $0.36 Est., Sales $1.32B vs $1.27B Est.; Sees FY Adj. EPS $1.61-$1.68, Sales $4.8B-4.9B",2015-02-11 07:01:00-05:00,ZTS,neutral
1412492.0,"Earnings Scheduled For February 11, 2015",2015-02-11 05:13:00-05:00,ZTS,neutral
1412493.0,UPDATE:  Zoetis Names William Doyle to Board,2015-02-04 08:35:00-05:00,ZTS,neutral
1412494.0,Zoetis Names William Doyle to Board,2015-02-04 08:35:00-05:00,ZTS,neutral
1412495.0,Hearing Bill Ackman to Win Zoetis Board Seats,2015-01-29 11:44:00-05:00,ZTS,positive
1412496.0,Ken Squire Shares His Activist Trades,2015-01-21 21:12:00-05:00,ZTS,positive
1412497.0,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3,2015-01-13 10:58:00-05:00,ZTS,neutral
1412498.0,Zoetis CEO Says Open to Inversion Deal -Wall Street Journal,2015-01-13 10:52:00-05:00,ZTS,neutral
1412499.0,Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio,2014-12-18 04:31:00-05:00,ZTS,negative
1412500.0,Zoetis Increases Qtr Dividend From $0.072 To  $0.083/share,2014-12-17 16:16:00-05:00,ZTS,neutral
1412501.0,"Ackman Declines Comment on Zoetis Investment, Says 'Too Early to Discuss'",2014-12-17 10:56:00-05:00,ZTS,neutral
1412502.0,"Cramer Comments On Alibaba, Zoetis",2014-12-16 07:19:00-05:00,ZTS,neutral
1412503.0,Benzinga's Top Initiations,2014-12-11 09:06:00-05:00,ZTS,positive
1412504.0,Cowen Initiates Zoetis With Market Perform,2014-12-11 08:52:00-05:00,ZTS,neutral
1412505.0,"Cowen & Company Initiates Coverage on Zoetis at Market Perform, Announces $47.00 PT",2014-12-11 05:55:00-05:00,ZTS,neutral
1412506.0,Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO,2014-12-09 15:02:00-05:00,ZTS,neutral
1412507.0,Zoetis Declines Comment on Talks with Sanofi,2014-12-09 12:29:00-05:00,ZTS,neutral
1412508.0,"Zoetis Falling Back From $44.49 High, Currently At $43.47",2014-12-09 11:28:00-05:00,ZTS,negative
1412509.0,Zoetis Shares Spike Higher; Calls Trading At Roughly 30 Times Normal Volume,2014-12-09 11:21:00-05:00,ZTS,positive
1412510.0,Sanofi's Weinberg Says Ready To Make Acquisitions In Vet Medicine,2014-12-09 11:18:00-05:00,ZTS,positive
1412511.0,Zoetis Spikes Higher; May be Attributed to Comments from Sanofi,2014-12-09 11:16:00-05:00,ZTS,neutral
1412512.0,Zoetis Spikes Higher,2014-12-09 11:15:00-05:00,ZTS,neutral
1412513.0,Top 4 NYSE Stocks In The Drugs-Generic Industry With The Highest Profit Margin,2014-12-09 05:09:00-05:00,ZTS,positive
1412514.0,"UPDATE: Pershing Had Shown Stake of 1.1% as of Nov. 11, 2014 on Zoetis",2014-12-05 16:20:00-05:00,ZTS,neutral
1412515.0,UPDATE: Filing from Ackman's Pershing on Zoetis Shows 8.3% Stake,2014-12-05 16:19:00-05:00,ZTS,neutral
1412516.0,Amended 13D Filing from Ackman's Pershing Square on Zoetis Just Filed,2014-12-05 16:18:00-05:00,ZTS,neutral
1412517.0,"Jefferies Raises Zoetis Price Target, Says Consolidation Continues To Look Likely",2014-11-26 09:03:00-05:00,ZTS,neutral
1412518.0,"Jefferies Maintains Buy on Zoetis, Raises PT to $53.00",2014-11-26 07:59:00-05:00,ZTS,neutral
1412519.0,Zoetis Announces Appointment Of Roman Trawicki As President Of Global Manufacturing And Supply,2014-11-24 09:01:00-05:00,ZTS,neutral
1412520.0,UPDATE: Bank Of America Reiterates On Zoetis On Enhanced Clarity On Long-Term Prospects,2014-11-19 09:40:00-05:00,ZTS,positive
1412521.0,"Bank of America Maintains Buy on Zoetis, Raises PT to $51.00",2014-11-19 04:07:00-05:00,ZTS,neutral
1412522.0,"Bill Ackman Has Not Yet Met with Zoetis Mgmt, Sees Need for Significant Cost Reductions",2014-11-18 18:11:00-05:00,ZTS,positive
1412523.0,Zoetis Says FX Accounts For Majority Of Variance In 2015 EPS Comparison To Estimates,2014-11-18 15:24:00-05:00,ZTS,neutral
1412524.0,UPDATE: Zoetis Shares Volatile But Largely Unch Following Worse-Than-Expected Outlook,2014-11-18 13:49:00-05:00,ZTS,positive
1412525.0,"Shares of Zoetis Resume, Now Down 1.3%",2014-11-18 13:46:00-05:00,ZTS,positive
1412526.0,"UPDATE: Zoetis Issues Release Outlining Strategy, Initiatives 'to Drive Growth, Create Shareholder Value' Highlighted at Investor Day",2014-11-18 13:41:00-05:00,ZTS,positive
1412527.0,Zoetis Issues Release: Sees FY2015 Sales $4.85B-4.95B vs $4.96B Est,2014-11-18 13:38:00-05:00,ZTS,neutral
1412528.0,From Zoetis 8-K: Sees FY2015 EPS $1.61-1.68 vs $1.71 Est,2014-11-18 13:37:00-05:00,ZTS,neutral
1412529.0,Zoetis Shares Halted News Pending,2014-11-18 13:32:00-05:00,ZTS,positive
1412530.0,Citigroup Offers Thoughts On Zoetis Ahead Of Investor Day,2014-11-18 09:11:00-05:00,ZTS,neutral
1412531.0,Zoetis Announces $500M Buyback Plan,2014-11-18 07:01:00-05:00,ZTS,neutral
1412532.0,"Benzinga's M&A Chatter for Monday November 17, 2014",2014-11-17 18:11:00-05:00,ZTS,neutral
1412533.0,Zoetis Announces Purchase of Assets of Abbott Animal Health for $255M,2014-11-17 08:15:00-05:00,ZTS,positive
1412534.0,Benzinga's Weekend M&A Chatter,2014-11-16 20:30:00-05:00,ZTS,neutral
1412535.0,Zoetis Announces One-Year Shareholder Rights Plan,2014-11-14 17:09:00-05:00,ZTS,neutral
1412536.0,Hilliard Lyons Downgrades Zoetis to Neutral,2014-11-13 09:40:00-05:00,ZTS,neutral
1412537.0,"All Quiet On The Market Front: Dow, S&P 500, Nasdaq Virtually Flat",2014-11-12 16:38:00-05:00,ZTS,neutral
1412538.0,Analyst: Bill Ackman's Zoetis Move Casts Doubt On Allergan Bid,2014-11-12 16:04:00-05:00,ZTS,negative
1412539.0,"Fast Money Traders Advise Viewers On Yahoo, Zoetis, JPMorgan And JetBlue",2014-11-12 15:55:00-05:00,ZTS,neutral
1412540.0,UPDATE: Morgan Stanley Upgrades Zoetis On Pershing Square News,2014-11-12 12:13:00-05:00,ZTS,neutral
1412541.0,Edward Jones Downgrades Zoetis to Hold,2014-11-12 11:00:00-05:00,ZTS,neutral
1412542.0,Zoetis Spiking Higher,2014-11-12 10:51:00-05:00,ZTS,neutral
1412543.0,Morgan Stanley Upgrades Zoetis to Equalweight,2014-11-12 09:58:00-05:00,ZTS,neutral
1412544.0,UPDATE: Citigroup Reiterates On Zoetis Following Pershing Confirmation,2014-11-12 09:03:00-05:00,ZTS,neutral
1412545.0,"Citigroup Maintains Buy on Zoetis, Raises PT to $49.00",2014-11-12 08:35:00-05:00,ZTS,neutral
1412546.0,UPDATE: Bank Of America Reiterates On Zoetis On Further Support For Fundamentals,2014-11-12 08:31:00-05:00,ZTS,positive
1412547.0,"UPDATE: Pershing Square Filing on Zoetis Shows 8.3% Stake, Says Firm Will Engage in Discussions; Separate 13D Filing from Sachem Head Capital Shows 0.9% Stake",2014-11-12 07:00:00-05:00,ZTS,positive
1412548.0,13D Filing from Pershing Square on Zoetis Just Out,2014-11-12 06:57:00-05:00,ZTS,neutral
1412549.0,"Bank of America Maintains Buy on Zoetis, Raises PT to $49.00",2014-11-12 04:23:00-05:00,ZTS,neutral
1412550.0,"Benzinga's M&A Chatter for Tuesday November 11, 2014",2014-11-11 21:05:00-05:00,ZTS,neutral
1412551.0,Pershing Square 13D Filing to Disclose ~8.5% Stake in Zoetis,2014-11-11 20:01:00-05:00,ZTS,neutral
1412552.0,Markets Little Changed As Investors And Traders Salute Veterans,2014-11-11 16:37:00-05:00,ZTS,neutral
1412553.0,Zoetis Soars On News Of Ackman Stake,2014-11-11 16:27:00-05:00,ZTS,neutral
1412554.0,"UPDATE: Valeant Shares Spike Higher on DJ Zoetis Could be Takeover Target for Valeant, According to Sources",2014-11-11 15:44:00-05:00,ZTS,positive
1412555.0,UPDATE: Pershing Square And Sachem Head Capital Take $2B Investment In Zoetis - According To Sources,2014-11-11 15:41:00-05:00,ZTS,neutral
1412556.0,"DJ Reports Bill Ackman's Pershing Square Takes Stake In Zoetis, According to Sources",2014-11-11 15:35:00-05:00,ZTS,neutral
1412557.0,Zoetis Spikes Higher,2014-11-11 15:35:00-05:00,ZTS,neutral
1412558.0,Zoetis Reports Q3 EPS of $0.33 vs $0.37 Est; Revenue of $1.20B vs $1.16B Est,2014-11-04 07:00:00-05:00,ZTS,neutral
1412559.0,"Hilliard Lyons Downgrades Zoetis to Long-term Buy, Raises PT to $42.00",2014-09-10 11:08:00-04:00,ZTS,neutral
1412560.0,UPDATE: Bank Of America Reiterates On Zoetis Inc Following Positive News,2014-09-04 08:29:00-04:00,ZTS,positive
1412561.0,Zoetis Announces Paul Herendeen CFO,2014-08-14 16:43:00-04:00,ZTS,neutral
1412562.0,Zoetis Sees FY2014 EPS $1.50-1.54,2014-08-05 07:09:00-04:00,ZTS,neutral
1412563.0,"Zoetis Reports Q2 EPS of $0.38, Inline; Revenue of $1.16B vs $1.16B Est",2014-08-05 07:09:00-04:00,ZTS,neutral
1412564.0,5 Drug Companies Profiting From Generics,2014-08-04 08:29:00-04:00,ZTS,positive
1412565.0,"Spin-Offs: Why Do Companies Do It, And What They Might Mean To Your Portfolio ",2014-08-01 15:43:00-04:00,ZTS,neutral
1412566.0,Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th,2014-06-10 11:04:00-04:00,ZTS,neutral
1412567.0, Zoetis CEO Alaix: 'We Will be Generating Significant Cash for Opportunities or to Return to Shareholders',2014-06-09 18:45:00-04:00,ZTS,positive
1412568.0, Zoetis CEO Juan Alaix: ' We are Investing Heavily in R&D',2014-06-09 18:43:00-04:00,ZTS,neutral
1412569.0,Jim Cramer Interviews CEO Juan Ram Alaix of Zoetis on Mad Money,2014-06-09 18:42:00-04:00,ZTS,negative
1412570.0,Benzinga's Top Downgrades,2014-05-07 08:42:00-04:00,ZTS,positive
1412571.0,Morgan Stanley Downgrades Zoetis to Underweight,2014-05-07 07:46:00-04:00,ZTS,neutral
1412572.0,Zoetis Reports Q1 EPS of $0.38 vs $0.37 Est; Revenue of $1.10B vs $1.13B Est,2014-05-06 07:00:00-04:00,ZTS,neutral
1412573.0,"Zoetis Appoints Glenn David as Acting CFO, Passov to Leave at End of April",2014-04-22 08:34:00-04:00,ZTS,negative
1412574.0,"Option Alert: Zoetis Oct $25 Put; 12,776 Contracts Traded vs 21 OI; Currently $28.64",2014-04-17 13:10:00-04:00,ZTS,positive
1412575.0,William Blair Upgrades Zoetis to Outperform,2014-02-12 07:53:00-05:00,ZTS,neutral
1412576.0,BofA Removed Zoetis from 'US 1' List,2014-02-12 07:43:00-05:00,ZTS,neutral
1412577.0,Mid-Afternoon Market Update: Markets Continue to Rally as InfoBlox Takes a Big Haircut,2014-02-11 15:33:00-05:00,ZTS,neutral
1412578.0,Zoetis Sees FY2014 EPS $1.48-1.54 vs $1.61 Est,2014-02-11 07:14:00-05:00,ZTS,neutral
1412579.0,Zoetis Reports Q4 EPS of $0.36 vs $0.34 Est; Revenue of $1.25B vs $1.21B Est,2014-02-11 07:14:00-05:00,ZTS,neutral
1412580.0,UPDATE: Morgan Stanley Downgrades Zoetis on Low Expectations for Catalysts in 2014,2014-01-08 08:25:00-05:00,ZTS,negative
1412581.0,"Morgan Stanley Downgrades Zoetis to Equal-weight, Removes $36.00 PT",2014-01-08 06:39:00-05:00,ZTS,neutral
1412582.0,Zoetis Raises Q1 Dividend 11% to $0.072,2013-12-19 08:34:00-05:00,ZTS,neutral
1412583.0,UPDATE: William Blair & Company Initiates Coverage on Zoetis on Good Earnings Growth Potential,2013-11-25 11:01:00-05:00,ZTS,positive
1412584.0,William Blair Initiates Coverage on Zoetis at Market Perform,2013-11-25 08:00:00-05:00,ZTS,neutral
1412585.0,3 ETFs That Will Buy Twitter,2013-11-11 16:29:00-05:00,ZTS,neutral
1412586.0,Zoetis Sees FY2013 EPS $0.98-1.02 vs $1.40 Est; Sees Sales $4.47B-4.53B vs $4.49B Est,2013-11-05 07:04:00-05:00,ZTS,neutral
1412587.0,"Zoetis Reports Q3 EPS of $0.34, Inline; Revenue of $1.10B vs $1.07B Est",2013-11-05 07:02:00-05:00,ZTS,neutral
1412588.0,"Twitter Sparks Interest in IPO ETFs (FPX, IPO, FB)",2013-10-28 11:40:00-04:00,ZTS,positive
1412589.0,"Stocks to Watch for October 14, 2013",2013-10-14 16:51:00-04:00,ZTS,neutral
1412590.0,"UPDATE: Morgan Stanley Upgrades Zoetis on Global Leader Position, Positive Outlook",2013-10-04 11:34:00-04:00,ZTS,positive
1412591.0,"Morgan Stanley Upgrades Zoetis to Overweight, Announces $36.00 PT",2013-10-04 06:30:00-04:00,ZTS,negative
1412592.0,Shares of Zoetis Up Nearly 2% Following Addition of Stock to BofA's 'US 1' List,2013-09-10 08:45:00-04:00,ZTS,positive
1412593.0,Zoetis Sees Q2 EPS $1.36-1.42; Sees Sales $4.42B-4.53B,2013-08-06 07:17:00-04:00,ZTS,neutral
1412594.0,Zoetis Reports Q2 EPS of $0.36; Revenue of $1.11B,2013-08-06 07:16:00-04:00,ZTS,neutral
1412595.0,"Cryoport, Zoetis Announce Expanded Relationship for Cold Chain Logistics",2013-07-22 12:07:00-04:00,ZTS,neutral
1412596.0,UPDATE: Jefferies Lowers PT on Zoetis on Challenges Ahead,2013-07-12 08:56:00-04:00,ZTS,negative
1412597.0,"Jefferies Maintains Buy on Zoetis, Lowers PT to $39.00",2013-07-12 07:27:00-04:00,ZTS,negative
1412598.0,J.P. Morgan Reiterates Overweight Rating on Zoetis Following Prizer Share Exchange,2013-07-08 08:49:00-04:00,ZTS,positive
1412599.0,UPDATE: Bank of America Upgrades Zoetis to Buy Citing Renewed Focus on Profit Margins,2013-07-05 09:01:00-04:00,ZTS,positive
1412600.0,Bank of America Upgrades Zoetis to Buy,2013-07-05 08:35:00-04:00,ZTS,neutral
1412601.0,Benzinga's Top Pre-Market Gainers ,2013-07-05 08:20:00-04:00,ZTS,positive
1412602.0,Pfizer Announces Final Results of Zoetis Exchange Offer ,2013-06-27 08:45:00-04:00,ZTS,neutral
1412603.0,"Argus Research Initiates Coverage on Zoetis at Buy, Announces $38.00 PT",2013-06-26 08:36:00-04:00,ZTS,neutral
1412604.0,Hilliard Lyons Upgrades Zoetis to Buy,2013-06-25 09:18:00-04:00,ZTS,neutral
1412605.0,Pfizer Announces Preliminary Results of Zoetis Exchange Offer and Adjusts 2013 Financial Guidance(1) Solely to Reflect Impact of Exchange Offer ,2013-06-24 09:13:00-04:00,ZTS,neutral
1412606.0,"Pfizer Issues Prelim. Results for Zoetis Exchange Offer, Says 1.68B Shares Tendered, Sees Separation Adding to EPS",2013-06-24 09:10:00-04:00,ZTS,positive
1412607.0,"UPDATE: Pfizer Reports Final Exchange Ratio of 0.9898 for Zoetis Exchange Offer, Extends Offer to Jun. 21st",2013-06-19 16:42:00-04:00,ZTS,positive
1412608.0,"UPDATE: Pfizer Offer Extended to Friday, June 21st, Will Accept 405.1M Shares If Fully Subscribed",2013-06-19 16:29:00-04:00,ZTS,positive
1412609.0,Pfizer Says Final Exchange Ratio for Zoetis at 0.9898,2013-06-19 16:28:00-04:00,ZTS,neutral
1412610.0,"BMO Says Pfizer, Zoetis Exchange Offer Looking More Attractive, Sees Bid at High End of Ratio",2013-06-19 11:56:00-04:00,ZTS,positive
1412611.0,"Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target to $19",2013-06-18 10:39:00-04:00,ZTS,positive
1412612.0,Zoetis to Replace First Horizon in S&P 500,2013-06-14 17:18:00-04:00,ZTS,neutral
1412613.0,"UPDATE: Pfizer Says Preparing for Potential IPO of Minority Stake, Will Provide Details on Possible Deal During Q2 Earnings",2013-06-11 17:43:00-04:00,ZTS,neutral
1412614.0,Hearing UBS Says Zoetis May be Added to S&P 500 Tonight,2013-06-11 13:46:00-04:00,ZTS,neutral
1412615.0,UPDATE: Jefferies Lowers PT on Zoetis Following SOTP Analysis,2013-05-28 10:58:00-04:00,ZTS,negative
1412616.0,"Jefferies Maintains Buy on Zoetis, Lowers PT to $40.00",2013-05-28 08:29:00-04:00,ZTS,negative
1412617.0,"PreMarket Info Recap for May 22, 2013",2013-05-22 09:17:00-04:00,ZTS,neutral
1412618.0,UPDATE: Pfizer to Split Off Remaining Interest in Zoetis,2013-05-22 08:03:00-04:00,ZTS,positive
1412619.0,Pfizer to Split Off Remaining Interest in Zoetis,2013-05-22 08:03:00-04:00,ZTS,positive
1412620.0,Zoetis Announces FDA Approval of Apoquel for Dogs,2013-05-16 08:07:00-04:00,ZTS,positive
1412621.0,Summary of 13F from Tiger Global,2013-05-16 07:19:00-04:00,ZTS,neutral
1412622.0,Zoetis Spikes Higher,2013-05-14 11:10:00-04:00,ZTS,neutral
1412623.0,Zoetis Sees FY2013 EPS $1.36-1.42; Sees Sales $4.42B-4.53B,2013-04-30 07:03:00-04:00,ZTS,neutral
1412624.0,Zoetis Reports Q1 EPS of $0.36 vs $0.33 Est; Revenue of $1.09B vs $1.08B Est,2013-04-30 07:03:00-04:00,ZTS,neutral
1412625.0,"BMO Capital Markets Reiterates Underperform Rating, $30 PT on Zoetis on Avian Flu Scare",2013-04-05 13:26:00-04:00,ZTS,negative
1412626.0,"BMO Capital Maintains Underperform on Zoetis, Raises PT to $30.00",2013-04-02 07:54:00-04:00,ZTS,neutral
1412627.0,Benzinga's Top Initiations,2013-03-21 07:52:00-04:00,ZTS,positive
1412628.0,"Citigroup Initiates Coverage on Zoetis at Buy, Announces $38.00 PT",2013-03-21 06:23:00-04:00,ZTS,neutral
1412629.0,UPDATE: Credit Suisse Initiates Zoetis at Neutral; Stock Captures Long-Term Tailwinds,2013-03-20 08:14:00-04:00,ZTS,positive
1412630.0,Benzinga's Top Initiations,2013-03-20 07:44:00-04:00,ZTS,positive
1412631.0,"Credit Suisse Initiates Coverage on Zoetis at Neutral, Announces $36.00 PT",2013-03-20 06:27:00-04:00,ZTS,positive
1412632.0,Barron's Recap (3/16/13): A New Way to Play Emerging Markets,2013-03-16 11:46:00-04:00,ZTS,positive
1412633.0,7 Analysts Initiate Coverage on Zoetis; Who to Believe?,2013-03-13 11:47:00-04:00,ZTS,neutral
1412634.0,Benzinga's Top Initiations,2013-03-13 08:32:00-04:00,ZTS,positive
1412635.0,UPDATE: Piper Jaffray Initiates Zoetis at Overweight on Growth Outlook,2013-03-13 08:31:00-04:00,ZTS,neutral
1412636.0,UPDATE: Jefferies Initiates Zoetis at Buy on Strong Growth Profile,2013-03-13 07:53:00-04:00,ZTS,positive
1412637.0,UPDATE: JP Morgan Initiates Zoetis at Overweight; Leadership Position Clear,2013-03-13 07:53:00-04:00,ZTS,positive
1412638.0,UPDATE: Deutsche Bank Initiates Zoetis at Buy; Market Leader with Global Infrastructure,2013-03-13 07:53:00-04:00,ZTS,neutral
1412639.0,UPDATE: Bank of America Initiates Zoetis at Neutral; Growth Outlook Reflected in Valuation,2013-03-13 07:49:00-04:00,ZTS,positive
1412640.0,UPDATE: Goldman Sachs Initiates Zoetis at Neutral; Upside Limited From Current Valuation,2013-03-13 07:49:00-04:00,ZTS,negative
1412641.0,UPDATE: Morgan Stanley Initiates Zoetis at Equal-Weight; Fundamentals Reflect Balanced Risk/Reward,2013-03-13 07:48:00-04:00,ZTS,neutral
1412642.0,"Jefferies Initiates Coverage on Zoetis at Buy, Announces $40.00 PT",2013-03-13 06:44:00-04:00,ZTS,neutral
1412643.0,"JP Morgan Initiates Coverage on Zoetis at Overweight, Announces $39.00 PT",2013-03-13 06:42:00-04:00,ZTS,neutral
1412644.0,Morgan Stanley Initiates Coverage on Zoetis at Equal-weight,2013-03-13 06:40:00-04:00,ZTS,neutral
1412645.0,"Goldman Sachs Initiates Coverage on Zoetis at Neutral, Announces $33.00 PT",2013-03-13 06:39:00-04:00,ZTS,neutral
1412646.0,"Piper Jaffray Initiates Coverage on Zoetis at Overweight, Announces $40.00 PT",2013-03-13 06:38:00-04:00,ZTS,negative
1412647.0,"Deutsche Bank Initiates Coverage on Zoetis at Buy, Announces $38.00 PT",2013-03-13 06:37:00-04:00,ZTS,neutral
1412648.0,"Bank of America Initiates Coverage on Zoetis at Neutral, Announces $35.00 PT",2013-03-13 06:29:00-04:00,ZTS,neutral
1412649.0,UPDATE: Hilliard Lyons Initiates Zoetis at Neutral on Valuation,2013-03-12 11:00:00-04:00,ZTS,neutral
1412650.0,Hilliard Lyons Initiates Coverage on Zoetis at Neutral,2013-03-12 09:30:00-04:00,ZTS,neutral
1412651.0,Hilliard Lyons Initiates Coverage on Zoetis at Neutral,2013-03-12 08:56:00-04:00,ZTS,neutral
1412652.0,UPDATE: BMO Capital Markets Initiates Zoetis at Underperform on Valuation,2013-03-08 08:15:00-05:00,ZTS,neutral
1412653.0,"BMO Capital Initiates Coverage on Zoetis at Underperform, Announces $28.00 PT",2013-03-08 07:27:00-05:00,ZTS,neutral
1412654.0,"BMO Capital Initiates Coverage on Zoetis at Underperform, Announces $28.00 PT",2013-03-07 16:52:00-05:00,ZTS,neutral
1412655.0,"Mid-Day Market Update: CARBO Ceramics Rising, Keyx Continues to Give Back Gains",2013-02-01 14:15:00-05:00,ZTS,positive
1412656.0,"Mid-Morning Market Update: Unemployment Reaches 7.9%, Zoetis IPO Wildly Successful",2013-02-01 10:39:00-05:00,ZTS,positive
1412657.0,Pfizer Offers Statement on Zoetis IPO,2013-02-01 09:58:00-05:00,ZTS,neutral
1412658.0,"Zoetis IPO Opens at $31.50/Share, Priced at $26",2013-02-01 09:47:00-05:00,ZTS,neutral
1412659.0,Zoetis IPO to Open Shortly,2013-02-01 09:46:00-05:00,ZTS,neutral
1412660.0,Seeing Quotes in the Range of $30-32 for Zoetis IPO,2013-02-01 09:38:00-05:00,ZTS,neutral
1412661.0,IPO for Pfizer's Zoetis Prices 86.1M Shares at $26/Share,2013-01-31 17:42:00-05:00,ZTS,positive
1412662.0,"ISI Group Initiates Coverage on Zoetis at Buy, Announces $30.00 PT",2013-01-31 16:12:00-05:00,ZTS,neutral
1412663.0,"Pfizer, Spinoff Zoetis Receive Positive Mad Money/Jim Cramer Mention -CNBC",2013-01-23 18:18:00-05:00,ZTS,positive
1412664.0,Will These 2 IPOs Flourish?,2013-01-22 13:19:00-05:00,ZTS,neutral
1412665.0,"UPDATE: Pfizer's Zoetis to Offer 86.1M Shares, Expects IPO Price of $22-25/Share",2013-01-17 17:03:00-05:00,ZTS,positive
